Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease.
作者:
主题词
动物(Animals);抗氧化剂(Antioxidants);基底神经节(Basal Ganglia);行为, 动物(Behavior, Animal);疾病模型, 动物(Disease Models, Animal);剂量效应关系, 药物(Dose-Response Relationship, Drug);HSP70热休克蛋白质类(HSP70 Heat-Shock Proteins);血红素氧化酶(脱环)(Heme Oxygenase (Decyclizing));人类(Humans);杭廷顿病(Huntington Disease);男(雄)性(Male);线粒体(Mitochondria);运动活动(Motor Activity);NAD(P)H脱氢酶(醌)(NAD(P)H Dehydrogenase (Quinone));NF-E2相关因子2(NF-E2-Related Factor 2);神经元(Neurons);神经保护药(Neuroprotective Agents);硝基化合物(Nitro Compounds);丙酸盐类(Propionates);大鼠, Sprague-Dawley(Rats, Sprague-Dawley);活性氧(Reactive Oxygen Species);皂角苷配基(Sapogenins);信号传导(Signal Transduction);时间因素(Time Factors);体重减轻(Weight Loss)
DOI
10.1038/aps.2014.107
PMID
25640478
发布时间
2022-03-11
- 浏览80

Acta pharmacologica Sinica
311-22页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文